At Creative Biolabs, we deliver encapsulation services that transform fragile biological and chemical payloads into stable, functional, and application-ready microstructures. This service hub provides a unified entry point to our encapsulation capabilities across cells, proteins, enzymes, bacteria, viruses, microbiomes, and active pharmaceutical ingredients (APIs).
Microfluidic encapsulation replaces stochastic mixing with deterministic physics—laminar flow, interfacial tension control, and real-time parameter tuning—delivering reproducibility by design. Built on advanced droplet microfluidics and flow-focusing architectures, our platforms enable deterministic control over particle size, composition, release kinetics, and payload distribution—at single-cell and single-droplet resolution.
Whether your goal is to preserve viability, enhance stability, enable targeted delivery, or standardize high-throughput screening, Creative Biolabs' microfluidic encapsulation solutions are designed to de-risk development and accelerate translation.
Our cell encapsulation workflows are optimized for single-cell isolation, 3D culture, immune-cell engineering, and regenerative research. By precisely tuning gelation kinetics and shear profiles, we preserve phenotype, viability, and functional outputs.
Proteins demand gentle handling and controlled microenvironments. Our microfluidic protein encapsulation minimizes interfacial stress and aggregation while enabling sustained or stimuli-responsive release.
We engineer enzyme microcapsules that retain catalytic activity while improving reusability and operational stability—ideal for biocatalysis, biosensing, and flow chemistry.
Microfluidic encapsulation enables single-bacterium confinement, controlled growth, and protection from environmental stress—critical for microbiology, synthetic biology, and probiotic R&D.
Our virus encapsulation services focus on maintaining structural integrity and infectivity (where applicable) while enhancing handling safety and experimental reproducibility.
We support multi-species co-encapsulation, enabling controlled interaction studies within defined microenvironments—an essential tool for microbiome mechanism-of-action research.
For poorly soluble or unstable APIs, microfluidic encapsulation offers uniform loading, enhanced dissolution profiles, and precise release modulation.
| Payload Type | Primary Objectives | Typical Outputs |
| Cells | Viability, clonality, protection | Single-cell microgels |
| Proteins | Stability, sustained release | Uniform protein microcapsules |
| Enzymes | Activity retention, reuse | Enzyme-loaded beads |
| Bacteria | Survival, containment | Live microbial microcapsules |
| Viruses | Integrity, biosafety | Encapsulated viral particles |
| Microbiome | Community balance | Multi-species droplets |
| APIs | Solubility, delivery | API-loaded microparticles |
Creative Biolabs follows a rigorous, phase-gated process to ensure the success of every custom encapsulation project.
The applications of our Custom Microfluidic Encapsulation Services are vast and continually expanding.
Development of smart "stimuli-responsive" carriers that release their cargo in response to pH, temperature, or enzyme triggers.
Encapsulating single cells with barcoded beads for droplet-based RNA sequencing (e.g., Drop-seq).
Developing digital PCR (dPCR) assays where DNA molecules are partitioned into millions of droplets for absolute quantification.
Protecting flavors, fragrances, and bioactive nutrients from oxidation and ensuring controlled release upon application.
"We evaluated several encapsulation strategies for single-cell studies, but only Creative Biolabs' microfluidic encapsulation platform consistently delivered true one-cell-per-droplet control while maintaining high post-encapsulation viability."
— Principal Investigator, Cell Engineering Program
"Protein aggregation and interfacial stress had been persistent challenges in our formulation work. The microfluidic protein encapsulation service helped us establish a far more reproducible and controllable process."
— Senior Scientist, Biopharmaceutical R&D
"As an academic user, we appreciated the flexibility of the service. The team adapted the encapsulation protocol to our limited material availability and provided clear technical guidance. The collaboration felt more like a joint development project than a standard service transaction."
— Postdoctoral Researcher, Translational Medicine Program
"The team helped us precisely control particle size distribution and encapsulation efficiency across multiple lipid compositions. What impressed us most was not just the chip design, but the systematic DOE-driven optimization and the high reproducibility across batches, which significantly de-risked our scale-up strategy."
— Principal Investigator, Academic Nanomedicine Lab
Massive and efficient encapsulation of single cells using a microfluidic device
A facile and efficient encapsulation of single cells relying on the massive and controllable production of droplets and collagen–alginate microgels using a microfluidic device is presented. High monodispersity and geometric homogeneity of both droplet and microgel generation were experimentally demonstrated based on the well-investigated microfluidic fabricating procedure. The reliability of the microfluidic platform for controllable, high-throughput, and improved single-cell encapsulation in monodisperse droplets and microgels was also confirmed. A single-cell encapsulation rate of up to 33.6% was achieved based on the established microfluidic operation.
Fig.1 Microfluidic single-cell encapsulation in droplets and collagen-alginate microgels.1,2
References
Created January 2026
A: Yes. Particle size, polydispersity index (PDI), and encapsulation efficiency can be systematically tuned by adjusting flow rate ratios, total flow rates, lipid or polymer composition, and solvent exchange dynamics. Our team typically employs iterative optimization or DOE-based strategies to meet your specific formulation targets.
A: We support a wide range of delivery systems, including lipid nanoparticles (LNPs), liposomes, polymeric nanoparticles, hybrid lipid–polymer systems, and nanoemulsions. Selection of the encapsulation system is guided by your payload characteristics, target application, and downstream requirements.
A: Project timelines depend on formulation complexity and optimization depth. Feasibility or single-condition encapsulation projects may be completed within 1–2 weeks, while multi-parameter optimization studies generally take several weeks. Clear milestones and regular technical updates are provided throughout the project.
A: To initiate a project, we recommend a brief technical discussion to clarify your payload type, target particle characteristics, intended application, and available materials. Based on this information, our scientists will propose a tailored encapsulation strategy and project plan aligned with your research goals.
A: Material selection is guided by the payload's physicochemical properties, the desired experimental duration, and downstream analytical requirements. Hydrogels are commonly chosen for biological systems, while polymeric or lipid-based matrices may be selected for stability or release-focused studies. Material screening can be incorporated into the project workflow.
Custom microfluidic encapsulation services from Creative Biolabs provide a powerful foundation. Contact our team to discuss your payload, application, and performance goals—and transform encapsulation from a limitation into a strategic advantage.